Showing results (501-510 of 541) with videos related to

Sort By:
Pageof 55
BMC Public Health|May 13, 2010
Prevalence of the metabolic syndrome in Pudong New Area of Shanghai using three proposed definitions among Chinese adultsWang-hong Xu, Xiao-nan Ruan, Xiao-jin Fu, et al.
BMC Cancer|February 2, 2024
The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective studyLeen Liao, Jinghua Tang, Zhigang Hong, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|February 19, 2014
[Value of muscle enzyme analysis in differential diagnosis of childhood myopathic hyper-creatine kinase-emia]Bing Mao, Hui Xiong, Hui Jiao, et al.
Cancer Medicine|October 26, 2023
A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesionsYuan Li, Bin Li, Rou Jiang, et al.
Frontiers in Psychiatry|September 9, 2020
Current Status, Diagnosis, and Treatment Recommendation for Tic Disorders in ChinaZhi-Sheng Liu, Yong-Hua Cui, Dan Sun, et al.
Eclinicalmedicine|October 4, 2024
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trialZi-Tong Zhang, Wei-Wei Xiao, Li-Ren Li, et al.
Ebiomedicine|June 26, 2022
Clinical actionability of triaging DNA mismatch repair deficient colorectal cancer from biopsy samples using deep learningWu Jiang, Wei-Jian Mei, Shuo-Yu Xu, et al.
Journal for Immunotherapy of Cancer|March 30, 2021
Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancerQiaoqi Sui, Dingxin Liu, Wu Jiang, et al.
Chinese Medical Journal|March 18, 2006
Clinical and laboratory survey of 65 Chinese patients with Leigh syndromeYan-ling Yang, Fang Sun, Yao Zhang, et al.
Cancer Causes & Control : CCC|May 16, 2007
Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese populationLi-Na Mu, Wei Cao, Zuo-Feng Zhang, et al.
Pageof 55